TAMPA, Fla., Feb. 18, 2016 -- PPJ Healthcare Enterprises Inc. (OTC Pink:PPJE) announced today that it has executed 7l contracts, including Valley Herbal in Los Angeles area, to perform medical marijuana testing. The Company expects to execute a total of 100 contracts over the next 90 days and estimates that it could generate about $20,000 in revenue per dispensary per year.
“The signing of these contracts puts us in the position of being able to hit the ground running when the doors open,” said Chandana Basu, CEO of PPJ Healthcare Enterprises Inc. “The opening of our testing facility coupled with our recently announced pain clinic are significant steps in the Company’s plans to expand our business and work with partners that need key elements that we can offer.”
The Company anticipates the lab could open as early as next 45 to 60 days.
“We are working diligently to grow shareholder value through these continuous partnership opportunities. This strategy will not only allow us to expand at a quicker pace, but allows us to share the expense and risks associated with opening clinics and labs,” Basu said.
Forward-looking Statements
Information in this release may contain statements about future expectations, plans, prospects or performance of PPJ Healthcare Enterprises Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be,” “expects,” “may affect,” “believed,” “estimate,” “project” and similar words and phrases are intended to identify such forward-looking statements. PPJ Healthcare Enterprises cautions you that any forward-looking information provided by or on behalf of PPJ Enterprise is not a guarantee of future performance. None of the information in this press release constituted or is intended as an offer to sell securities or investment advice of any kind. PPJ Healthcare Enterprises’ actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond PPJ Enterprise’s control. In addition to those discussed in PPJ Healthcare Enterprises’ press releases, public filings and statements by PPJ Healthcare Enterprises’ management, including, but not limited to, PPJ Healthcare Enterprises’ estimate of sufficiency of its existing capital resources, PPJ Healthcare Enterprises’ ability to raise additional capital to fund future operations, PPJ Healthcare Enterprises’ ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match PPJ Healthcare Enterprises’ capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. PPJ Healthcare Enterprises does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made to reflect the occurrence of unanticipated events.
PPJ Healthcare Enterprises, Inc.
401 E. Jackson St., Suite 2340
Tampa, Florida 33602
Telephone: (813) 693-5192
Fax: (866) 622-3215
Websites: https://www.ppjenterprise.com
http://ppjenterprisedotorg.wordpress.com
https://www.automatedbiller.com
https://www.professionalbillingservice.net
https://www.facebook.com/PPJEnterprise
https://www.linkedin.com/pub/chandana-basu/76/6a1/137
https://www.twitter.com/PPJEnterprise


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FDA Approves Mitapivat for Anemia in Thalassemia Patients
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 



